Posters
Evaluation of Pharmacist-Led Clinical Interventions for Mavacamten within an Integrated Health System Specialty Pharmacy Care Model
Mavacamten is a first in class myosin inhibitor used in the treatment of obstructive hypertrophic cardiomyopathy (oHCM).